Introduction: The International Council for Harmonisation (ICH) is a global body that develops harmonized guidelines on quality, safety, efficacy and multidisciplinary topics to streamline pharmaceutical regulation and improve public health. B. Pharm students should understand ICH organization, guideline categories (Q, S, E, M), regulatory objectives, Common Technical Document (CTD), pharmacovigilance, quality systems (Q8–Q10), and drug development principles. Knowledge of ICH processes, implementation and key documents (eCTD, GCP, MedDRA) helps future pharmacists navigate regulatory submissions, product lifecycle management and risk-based decision-making. This focused review explains structure, objectives and practical applications for industry and regulators. ‘Now let’s test your knowledge with 30 MCQs on this topic.’
Q1. What does ICH stand for?
- International Conference for Harmonisation of Technical Requirements for Pharmaceuticals
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- International Committee for Health Regulations
- International Coalition for Healthcare
Correct Answer: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Q2. In which year was ICH originally established?
- 1985
- 1990
- 2000
- 2015
Correct Answer: 1990
Q3. What is the primary objective of ICH?
- To create global manufacturing facilities
- To harmonize technical requirements for pharmaceutical registration to ensure safer, more effective medicines
- To fund drug development in low-income countries
- To regulate hospital pharmacy operations
Correct Answer: To harmonize technical requirements for pharmaceutical registration to ensure safer, more effective medicines
Q4. Which are the main ICH guideline categories?
- Quality, Safety, Efficacy and Multidisciplinary
- Clinical, Regulatory, Production and Marketing
- Synthesis, Toxicology, Formulation and Distribution
- Quality Control, Legal, Ethical and Economic
Correct Answer: Quality, Safety, Efficacy and Multidisciplinary
Q5. What does CTD refer to in ICH terminology?
- Clinical Trial Database
- Common Technical Document
- Centralized Testing Directive
- Clinical Toxicology Dossier
Correct Answer: Common Technical Document
Q6. Which ICH guideline module is M4 associated with?
- Stability testing requirements
- CTD structure for regulatory submissions
- Good Clinical Practice
- MedDRA maintenance
Correct Answer: CTD structure for regulatory submissions
Q7. Which ICH guideline addresses Good Clinical Practice?
- E6
- Q10
- S3
- M2
Correct Answer: E6
Q8. Which guideline primarily deals with stability testing of new drug substances and products?
- Q1
- E2
- S7
- M4
Correct Answer: Q1
Q9. ICH Q9 provides guidance on which topic?
- Ethnic factors in clinical trials
- Quality Risk Management
- Clinical study report format
- Biotechnology product safety
Correct Answer: Quality Risk Management
Q10. What is the focus of ICH Q10?
- Pharmaceutical Quality System
- Adverse event reporting timelines
- Nonclinical pharmacology
- Clinical trial randomization
Correct Answer: Pharmaceutical Quality System
Q11. In the ICH guideline development process, what does Step 4 generally represent?
- Initial concept approval
- Public consultation
- Implementation by regulatory authorities
- Topic retirement
Correct Answer: Implementation by regulatory authorities
Q12. Which regions were the original regulatory founders of ICH?
- United States, European Union and Japan
- India, China and Brazil
- Australia, Canada and South Africa
- World Health Organization and UNICEF
Correct Answer: United States, European Union and Japan
Q13. Which global health organization has observer status in ICH activities?
- World Health Organization (WHO)
- United Nations Development Programme (UNDP)
- World Trade Organization (WTO)
- World Bank
Correct Answer: World Health Organization (WHO)
Q14. Which CTD module contains clinical study reports?
- Module 1
- Module 3
- Module 5
- Module 2
Correct Answer: Module 5
Q15. What does eCTD stand for?
- electronic Clinical Trial Database
- electronic Common Technical Document
- enhanced Clinical Trial Dossier
- electronic Chemical Toxicology Document
Correct Answer: electronic Common Technical Document
Q16. Which ICH guideline series specifically addresses impurities in drug substances and products?
- Q3
- E3
- M1
- S2
Correct Answer: Q3
Q17. ICH S6 provides guidance on which area?
- Preclinical safety evaluation of biotechnology-derived pharmaceuticals
- Quality risk management
- Clinical trial statistical analysis
- Labeling requirements
Correct Answer: Preclinical safety evaluation of biotechnology-derived pharmaceuticals
Q18. Which ICH guideline deals with periodic safety update reports for marketed products?
- E2C
- Q8
- S1
- M4
Correct Answer: E2C
Q19. What is MedDRA?
- A manufacturing quality audit tool
- Medical Dictionary for Regulatory Activities
- Method for Drug Release Assessment
- Module for Drug Therapeutics Assessment
Correct Answer: Medical Dictionary for Regulatory Activities
Q20. What is the role of the ICH Steering Committee?
- To provide strategic direction and oversight for guideline development and implementation
- To manufacture pharmaceuticals for member countries
- To conduct clinical trials on behalf of regulators
- To certify pharmacists worldwide
Correct Answer: To provide strategic direction and oversight for guideline development and implementation
Q21. ICH E5 guidance addresses which key issue?
- Ethnic factors in the acceptability of foreign clinical data
- Quality control of excipients
- Nonclinical toxicology study design
- API crystallization processes
Correct Answer: Ethnic factors in the acceptability of foreign clinical data
Q22. What is the focus of ICH Q8?
- Pharmaceutical Development
- Adverse event coding
- Clinical trial insurance
- Marketing authorization fees
Correct Answer: Pharmaceutical Development
Q23. Which guideline provides GMP guidance specifically for active pharmaceutical ingredients (APIs)?
- Q7
- E6
- S4
- M3
Correct Answer: Q7
Q24. Who is responsible for implementing ICH guidelines into local regulations?
- National regulatory authorities and industry stakeholders
- Only pharmaceutical companies
- Only the ICH Secretariat
- Hospital ethics committees
Correct Answer: National regulatory authorities and industry stakeholders
Q25. What is the main purpose of the Common Technical Document (CTD)?
- To harmonize the format and content of regulatory marketing authorization submissions
- To provide clinical trial enrollment software
- To standardize laboratory equipment calibration
- To outline patient counseling procedures
Correct Answer: To harmonize the format and content of regulatory marketing authorization submissions
Q26. ICH Q11 provides guidance on which subject?
- Development and manufacture of drug substances (small molecules)
- Post-marketing surveillance reporting
- Clinical trial statistical analysis plans
- Medical device co-marketing
Correct Answer: Development and manufacture of drug substances (small molecules)
Q27. Which risk assessment tool is commonly recommended under ICH Q9?
- Kaplan-Meier analysis
- Failure Mode and Effects Analysis (FMEA)
- ANOVA
- Chi-square test
Correct Answer: Failure Mode and Effects Analysis (FMEA)
Q28. Which ICH guideline series focuses on clinical safety data management and reporting of adverse events?
- E2
- Q3
- M1
- Q10
Correct Answer: E2
Q29. Which is a direct benefit of ICH harmonization for pharmaceutical development?
- Increased duplication of nonclinical studies
- Reduced regulatory predictability
- Avoidance of redundant testing and streamlined global submissions
- Elimination of national regulatory authorities
Correct Answer: Avoidance of redundant testing and streamlined global submissions
Q30. Who can propose new topics or revisions for ICH guidelines?
- Regulatory authorities and industry representatives (ICH members)
- Only international non-governmental organizations
- Only academic institutions
- Only manufacturing companies outside ICH regions
Correct Answer: Regulatory authorities and industry representatives (ICH members)
I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com